Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¸ÞµðÄõð¹ÙÀ̽º > ¹ÙÀÌ¿ÀÀåºñ > ÀÓ»óÈ­ÇÐ ¹× ¸é¿ªÁø´Ü ±â¼ú : ½ÅÈï ±â¼ú
Ä«Å×°í¸®
¸ÞµðÄõð¹ÙÀ̽º (4695)
³»½Ã°æ (161)
ºÐÀÚ¿µ»ó/Á¶¿µÁ¦ (28)
½ÉÇ÷°üÀåÄ¡ (338)
¾È°ú±â±â (102)
ÀÇ·á¿ë ¿µ»óÁø´ÜÀåÄ¡ (416)
ÀÇ·á¿ë ÀÏȸ¿ëǰ (77)
Á¤Çü¿Ü°ú (341)
â»ó°ü¸® (163)
ü¿ÜÁø´ÜÀåÄ¡(IVD) (527)
ÃÊÀ½ÆÄ (55)
Ä¡°ú±â±â (176)
Ä«Å×ÅÍ (239)
ÇÙÀÇ·á (76)
ÇコÄɾî IT (314)
ȯÀÚ¸ð´ÏÅ͸µ (391)
CT/MRI/X-ray (173)
½ÃÀ庸°í¼­

ÀÓ»óÈ­ÇÐ ¹× ¸é¿ªÁø´Ü ±â¼ú : ½ÅÈï ±â¼ú

Emerging Clinical Chemistry And Immunodiagnostic Technologies

¸®¼­Ä¡»ç Venture Planning Group
¹ßÇàÀÏ 2011³â 12¿ù »óǰÄÚµå 225038
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 1,500 £Ü 1,781,200 PDF by E-mail (Local license)
US $ 3,300 £Ü 3,918,700 PDF by E-mail (Global license)


Venture Planning Group ¿¡¼­ 2011³â 12¿ù ¿¡ ¹ßÇàÇÑ ¡¸ÀÓ»óÈ­ÇÐ ¹× ¸é¿ªÁø´Ü ±â¼ú : ½ÅÈï ±â¼ú¡¹ º¸°í¼­´Â US $1,500 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

ÀÓ»óÈ­ÇÐ(Clinical Chemistry) ¹× ¸é¿ªÁø´Ü(Immunodiagnostic) ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, IT, ºÐÀÚÁø´Ü, ¸é¿ªÃøÁ¤¹ý(Immunoassays), µå¶óÀÌ Äɹ̽ºÆ®¸®(Dry Chemistry) µî ½ÅÈï ±â¼ú°ú ±× ÀáÀçÀû ½ÃÀå¿¡¼­ÀÇ ÀÀ¿ë¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

Á¦1Àå ´ÜÀÏŬ·Ð Ç×ü¿Í ´ÙÁßŬ·Ð Ç×ü

Á¦2Àå ¸é¿ªÃøÁ¤¹ý(Immunoassays)

  • ±â¼úÀû ¿ø¸®
  • ¹æ»ç¸é¿ªÃøÁ¤¹ý(RIA)
  • È¿¼Ò¸é¿ªÃøÁ¤¹ý(EIA)
  • Çü±¤¸é¿ªÃøÁ¤¹ý(FIA)
  • ¹ß±¤
  • ¶óÅØ½º ÀÀÁý(LA)
  • ¸é¿ªÄ§°­¹ý
  • ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
  • Flow-injection Liposome Immunoanalysis(FIIA)

Á¦3Àå IT¿Í ¿ÀÅä¸ÞÀ̼Ç

Á¦4Àå µå¶óÀÌ Äɹ̽ºÆ®¸®(Dry Chemistry)

Á¦5Àå ¹ÙÀÌ¿À¼¾¼­

Á¦6Àå ·Îº¿ °øÇÐ

Á¦7Àå ºÐÀÚÁø´Ü

  • °Ë»ç Çü½Ä
    • ÇÊÅÍ ÇÏÀ̺긮´ÙÀÌÁ¦À̼Ç
    • ¼­´ø ºí·Ô
    • ³ë´ø ºí·Ô
    • °¡½ÃÀû ºÐÀÚ°áÇÕÈ­(In Situ Hybridization)
    • ±âŸ
  • Ç¥Áö¹ý
  • ÁõÆø¹ý
    • ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR)
    • »ç½½ ġȯ ÁõÆø
    • TMA
    • ¸®°¡Á¦¿¬¼â¹ÝÀÀ(LCR, Ligase Chain Reaction)
    • ºÐ±â DNA
    • Á¤·® ÇÙ»êÁõÆø°ËÁ¤¹ý(NASBA)
    • ÀÚÀ² ¹è¿­ ·¹Çø®Ä«¾ÆÁ¦
    • ±âŸ

Á¦8Àå Äɸð¸ÞÆ®¸¯½º(°³·®È­ÇÐ)

  • °ËÃâ ±â¼ú
    • ¹æ»ç¼º ¹æ¹ý
    • ºñµ¿À§Ã¼ ¹æ¹ý
LSH
Back to Top